Wird geladen...
Choosing Alzheimer’s disease prevention clinical trial populations
To assist investigators in making design choices, we modeled Alzheimer’s disease (AD) prevention clinical trials. We used longitudinal Clinical Dementia Rating Scale Sum of the Boxes data, retention rates, and the proportions of trial eligible cognitively normal participants age 65 and older in the...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2013
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3864603/ https://ncbi.nlm.nih.gov/pubmed/24119546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neurobiolaging.2013.09.001 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|